Tower Research Capital LLC (Trc) Athenex, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.12 - $0.21 $2,249 - $3,936	-18,747 Reduced 99.47%	99 $0
Q3 2022 Nov 10, 2022	BUY	$0.24 - $1.11 $324 - $1,499	1,351 Added 7.72%	18,846 $5,000
Q2 2022 Aug 15, 2022	BUY	$0.41 - $0.91 $1,254 - $2,783	3,059 Added 21.19%	17,495 $7,000
Q1 2022 May 12, 2022	SELL	$0.79 - $1.59 $4,856 - $9,773	-6,147 Reduced 29.86%	14,436 $12,000
Q4 2021 Feb 14, 2022	SELL	$1.36 - $2.94 $12,109 - $26,177	-8,904 Reduced 30.2%	20,583 $28,000
Q3 2021 Nov 15, 2021	BUY	$2.97 - $4.84 $60,267 - $98,213	20,292 Added 220.69%	29,487 $88,000
Q2 2021 Aug 16, 2021	SELL	$3.71 - $5.13 $163,674 - $226,320	-44,117 Reduced 82.75%	9,195 $43,000
Q1 2021 May 17, 2021	BUY	$4.08 - $14.75 $177,333 - $641,094	43,464 Added 441.35%	53,312 $230,000
Q4 2020 Feb 16, 2021	BUY	$11.06 - $14.01 $83,392 - $105,635	7,540 Added 326.69%	9,848 $109,000
Q3 2020 Nov 16, 2020	SELL	$10.26 - $14.55 $79,022 - $112,064	-7,702 Reduced 76.94%	2,308 $28,000
Q2 2020 Aug 13, 2020	BUY	$7.11 - $13.76 $71,171 - $137,737	10,010 New	10,010 $137,000
Q4 2019 Feb 07, 2020	SELL	$9.6 - $17.75 $71,414 - $132,042	-7,439 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$12.16 - $21.0 $79,076 - $136,563	6,503 Added 694.76%	7,439 $90,000
Q2 2019 Aug 13, 2019	SELL	$9.44 - $19.8 $49,295 - $103,395	-5,222 Reduced 84.8%	936 $19,000
Q1 2019 May 14, 2019	BUY	$11.11 - $13.49 $68,415 - $83,071	6,158 New	6,158 $75,000
Q4 2018 Feb 14, 2019	SELL	$10.24 - $15.49 $95,907 - $145,079	-9,366 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$15.53 - $19.97 $145,453 - $187,039	9,366 New	9,366 $146,000
Q2 2018 Aug 15, 2018	SELL	$15.88 - $19.5 $248,776 - $305,487	-15,666 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$13.53 - $17.47 $211,960 - $273,685	15,666 New	15,666 $266,000
Q4 2017 Feb 09, 2018	SELL	$14.41 - $19.15 $4,265 - $5,668	-296 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$13.5 - $19.51 $3,996 - $5,774	296	296 $5,000

Others Institutions Holding ATNX

# of Institutions

Shares Held

1.46M

Call Options Held

Put Options Held

Empery Asset Management, LP New York, NY

1.45M
Shares

$14,521
2.33% of portfolio
Eaton Vance Management Boston, MA

12K
Shares

$120
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Athenex, Inc.

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

More about ATNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account